Hot flashes happened less often and were less severe in women who took elinzanetant compared to those who took a placebo. The ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.

A new treatment for hot flashes brought relief and a better night’s rest for women experiencing these disruptive symptoms during menopause. Two phase 3 clinical trials compared the drug ...

Fezolinetant (Veozah), the first of a new class of non-hormonal ... and Drug Administration in 2023 for the treatment of moderate to severe hot flashes. This class of drugs targets a specific ...

"Last year, the FDA approved a new type of medication for the treatment of moderate to severe hot flashes called fezolinetant (brand name Veozah)," adds Nonacs. Minkin says that herbal remedies ...

And while these treatment options seem promising, their relatively new availability can make it ... involved about 400 women whose hot flashes and sleep disturbance symptoms were moderate to ...

"There is a huge unmet need for new treatments for hot flashes. Menopausal women who cannot take hormone therapy due to health issues or choose not to take it need more non-estrogen options to ...

Medications and natural remedies may also help treat hot flashes. Talk to your doctor before starting on any new medications or natural remedies. If you experience repeat hot flashes that don’t ...